Abstract-Upregulation of angiotensin II type 1 receptors (AT 1 R) in the rostral ventrolateral medulla (RVLM) contributes to the sympathoexcitation in the chronic heart failure (CHF). However, the role of angiotensin II type 2 receptor (AT 2 R) is not clear. In this study, we measured AT 1 R and AT 2 R protein expression in the RVLM and determined their effects on renal sympathetic nerve activity, blood pressure, and heart rate in anesthetized sham and CHF rats. We found that (1) although AT 1 R expression in the RVLM was upregulated, the AT 2 R was significantly downregulated t is well accepted that chronic heart failure (CHF) is characterized by heightened sympathetic tone. 1 This excessive sympathetic outflow to the heart and peripheral vessels attempts to increase myocardial performance and increases peripheral resistance, thereby contributing to an increase in myocardial oxygen consumption leading to a further deterioration in cardiac function. 2 It has been well established that activation of angiotensin II type 1 receptors (AT 1 R) in the rostral ventrolateral medulla (RVLM) evokes sympathetic excitation and pressor effects in normal animals. [3] [4] [5] Data from a previous study 6 from our laboratory further suggested that the upregulated AT 1 R expression in the RVLM and its enhanced intracellular signaling transduction plays a critical role in the sympathoexcitation in the CHF state. In addition, Ito et al 7 demonstrated that activation of AT 1 R in the RVLM appears to be important for the maintenance of hypertension in spontaneously hypertensive rats, another animal model of sympathoexcitation.
I
t is well accepted that chronic heart failure (CHF) is characterized by heightened sympathetic tone. 1 This excessive sympathetic outflow to the heart and peripheral vessels attempts to increase myocardial performance and increases peripheral resistance, thereby contributing to an increase in myocardial oxygen consumption leading to a further deterioration in cardiac function. 2 It has been well established that activation of angiotensin II type 1 receptors (AT 1 R) in the rostral ventrolateral medulla (RVLM) evokes sympathetic excitation and pressor effects in normal animals. [3] [4] [5] Data from a previous study 6 from our laboratory further suggested that the upregulated AT 1 R expression in the RVLM and its enhanced intracellular signaling transduction plays a critical role in the sympathoexcitation in the CHF state. In addition, Ito et al 7 demonstrated that activation of AT 1 R in the RVLM appears to be important for the maintenance of hypertension in spontaneously hypertensive rats, another animal model of sympathoexcitation.
In contrast with the AT 1 R, the functions of central angiotensin II type 2 receptors (AT 2 R) regarding the regulation of autonomic system are not well understood. Although the AT 2 R predominates in the tissues during fetal development, 8 this receptor has been identified to exist in many adult mammalian tissues, including the brain. 9 Further experiments have demonstrated that central regions related to sympathetic function such as the hypothalamus and brainstem exhibit positive AT 2 R mRNA hybridization signals, 10 implying the involvement of AT 2 R in the regulation of sympathetic outflow. Kang et al 11 found that, in the cultured neurons from newborn rat hypothalamus and brainstem, stimulation of AT 2 R significantly increased neuronal voltage-gated potassium channel current (I kv ) and that the third intracellular loop of the AT 2 R is a key component for this effect. 12 This group further determined that the phospholipase A2/arachidonic acid/12-lipoxygenases pathway mediates the modulation of potassium currents by activation of the AT 2 R. 13 These data strongly suggest that the AT 2 R exhibits an inhibitory effect on neuronal function by increasing potassium current and therefore decreasing excitability of neurons. Indeed, a recent study by Matsuura et al 14 demonstrated an AT 2 R-mediated hyper-polarization and decrease in firing rate of RVLM presympathetic neurons using the whole-cell patch-clamp technique in AT 1 R knockout mice. However, there are no reports concerning the effects of activating RVLM AT 2 R on sympathetic outflow and cardiovascular function in either normal or pathological conditions. In the current experiment, we measured both AT 1 R and AT 2 R protein expression in the RVLM from sham and CHF rats. We also observed the effects of stimulating RVLM AT 2 R and/or AT 1 R on renal sympathetic nerve activity (RSNA), arterial blood pressure, and heart rate (HR) in the anesthetized sham and CHF rats to determine the physiological and pathological significance of AT 2 R on autonomic regulation.
Methods
Forty-seven male Sprague-Dawley rats (Sasco, Wilmington, Mass) weighing between 290 and 380 g were used in these experiments. All experiments were approved by the Institutional Animal Care and Use Committee of the University of Nebraska Medical Center and were carried out under the guidelines of the American Physiological Society and the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Induction of Rat CHF Model
CHF was induced by coronary artery ligation as previously described. 15 See the online data supplement available at http://hyper. ahajournals.org for the details.
Acute Experiments
The acute experiment, including the general animal preparation, recording of RSNA, and RVLM microinjection procedures, were carried out as previously described. 15 See the online data supplement for details.
Preparation of RVLM and Western Blot Analysis
In a separate group of rats than those used for the previously mentioned microinjections, brains were removed and immediately frozen on dry ice, blocked in the coronal plane, and sectioned at 100-m thickness in a cryostat. The RVLM was punched using the technique of Palkovits and Brownstein 16 and homogenized in RIPA buffer. Protein extraction from homogenates was used to analyze AT 1 R and AT 2 R expression by Western blot. The concentration of protein extracted was measured using a protein assay kit (Pierce, Rockford, Ill) and adjusted to the same with equal volumes of 2ϫ 4% SDS sample buffer. The samples were boiled for 5 minutes followed by loading on a 7.5% SDS-PAGE gel (10 g protein/30 L per well) for electrophoresis using a Bio-Rad minigel apparatus at 40 mA/gel for 45 minutes. The fractionized protein on the gel was transferred onto a polyvinylidene fluoride membrane (Millipore) and electrophoresed at 300 mA for 90 minutes. The membrane was probed with primary antibodies (AT 1 R rabbit polyclonal antibody, Santa Cruz, 1:1000; AT 2 R rabbit polyclonal antibody, Santa Cruz, 1:1000) and secondary antibody (goat antirabbit IgG-HRP, Santa Cruz, 1:2500) and then treated with enhanced chemiluminescence substrate (Pierce) for 5 minutes at room temperature. The bands in the membrane were visualized and analyzed using UVP BioImaging Systems.
Statistical Analyses
All data are described as the meanϮSEM. The integrated RSNA before agent intervention was set as a 100% of baseline. The change in RSNA induced by a given agent was described as a percent of baseline. A 1-way or 2-way analysis of variance was used followed by either the Newman-Keuls or Bonferroni post hoc analysis where appropriate. Statistical analysis was done with the aid of SAS software. PϽ0.05 was considered statistically significant.
Results

Baseline Physiological Parameters of Sham and CHF Rats
The Table summarizes the baseline characteristics of sham and CHF rats used in the present experiment. In the rats with CHF, gross examination revealed a dense scar in the anterior ventricular wall and the mean infarct area was 41.5Ϯ3.6% of the left ventricular area. No infarcts were found in shamoperated rats. Corresponding to this morphological alteration was a marked decrease in cardiac function of CHF rats. Left ventricular end diastolic pressure was significantly elevated and ejection fraction was significantly lowered in the CHF rats compared with sham rats. Moreover, many CHF rats exhibited pulmonary edema, hydrothorax, and ascites. However, there were no significant differences in the arterial blood pressure and heart rate between sham and CHF rats. Figure 1 shows the AT 1 R and AT 2 R protein expressions in the RVLM of sham and CHF rats. CHF rats exhibited higher AT 1 R expression than that in sham rats similar to results we found previously in CHF rabbits. 6 Interestingly, from the same RVLM tissue sample, we found a lower AT 2 R expression from CHF RVLM rats compared with sham rats. These data suggest that, in the CHF state, although AT 1 R expression in the RVLM was upregulated, AT 2 R expression was significantly downregulated. In normal conditions, the level of AT 2 R expression in the RVLM is only half of AT 1 R expression. In the CHF state, this disparity of AT 1 R and AT 2 R expression was increased due to the upregulated AT 1 R and the downregulated AT 2 R. Angiotensin II (Ang II) activates both AT 1 R and AT 2 R. The ratio of these 2 angiotensin receptors therefore determines the final effects of Ang II in a specific tissue or organ. From Figure 1D , it can be seen that in CHF rats, the ratio of AT 1 R to AT 2 R was markedly increased compared with that from sham rats (13.8Ϯ0.7 versus 2.1Ϯ0.4, respectively, PϽ0.01; Figure 1D ). Figure 2 shows the functional identification of the RVLM by microinjection of L-glutamate. A transient pressor, tachycardia, and sympathoexcitatory response was induced by microinjection of L-glutamate (5 nmol in 50 nL) unilaterally into the RVLM. This functional test was routinely carried out using one barrel of a 3-barreled micropipette before each reagent was given.
Expression of AT 1 R and AT 2 R in the RVLM of Sham and CHF Rats
Effects of Stimulating RVLM AT 1 R and/or AT 2 R on RSNA and BP in Sham and CHF Rats
Functional Location of RVLM by L-Glutamate
Simultaneously Activating AT 1 R and AT 2 R by Ang II Figure 3 shows the cardiovascular and sympathetic responses to microinjection of Ang II (50 pmol in 50 nL) unilaterally into the RVLM to stimulate AT 1 R and AT 2 R. Ang II induced sympathoexcitation in both sham (146.7Ϯ9.4% of baseline) and CHF (235.3Ϯ11.6% of baseline) rats with a significantly larger response in the CHF rats (PϽ0.01). The enhanced sympathetic response to Ang II in the CHF state may be due to upregulation of AT 1 R expression, downregulation of AT 2 R expression, or both. The increase in mean arterial pressure (MAP) and HR were however similar between the 2 groups (⌬MAPϭ24.7Ϯ3.6 mm Hg, ⌬HRϭ21.3Ϯ6.4 beats/min for sham and ⌬MAPϭ28.1Ϯ2.3 mm Hg, ⌬HRϭ26.9Ϯ8.2 beats/min for CHF rats).
Activating AT 1 R by Ang II Plus PD123319 Figure 4A shows the cardiovascular and sympathetic responses to microinjection of Ang II (50 pmol in 50 nL) Figure 4B . Activating AT 2 R by CGP42112 Figure 5 shows the cardiovascular and sympathetic responses to microinjection of CGP42112 unilaterally into the RVLM in normal rats. CGP42112 (50 pmol in 50 nL) evoked a decrease in blood pressure (⌬MAPϭϪ31.3Ϯ4. Figure 6 .
Discussion
It has long been known that activation of AT 1 R in the RVLM evokes an increase in sympathetic outflow. 4 ,17 AT 1 R activation in the RVLM plays a critical role in the sympathoexcitation in the CHF state. 6 However, the role of AT 2 R in modulation of sympathetic outflow in CHF is completely unknown. The major novel findings from the present study are that (1) AT 2 R protein expression in the RVLM of CHF rats was significantly lower than that in sham rats; (2) microinjection of Ang II plus the AT 2 R antagonist, PD123319, into the RVLM produced a larger hypertension and sympathoexcitation than Ang II alone in sham but not in CHF rats; and (3) microinjection of the AT 2 R agonist, CGP42112, into the RVLM evoked hypotension, bradycardia, and sympathoinhibition in sham rats, but not in CHF rats. These results document that AT 2 R expression in the RVLM is downregulated in CHF rats and that AT 2 R stimulation in the RVLM exhibited an inhibitory effect on sympathetic outflow in the normal condition. These data suggest that suppressed AT 2 R signaling may be involved in the sympathetic overactivity in the CHF state. Sympathetic nerve activity is regulated at several central loci, including the subfornical organ, the area postrema, the paraventricular nucleus in the hypothalamus, and the nucleus of solitary tract and RVLM in the medulla. 18 Of these structures, the RVLM is an important region in maintaining tonic activity of sympathetic nerve outflow. 19 By directly projecting to sympathetic preganglionic neurons of the spinal cord and receiving inputs from other sympathetic-related central nuclei, the RVLM acts as a final common pathway in transferring signals from more rostral structures to peripheral sympathetic nerves. A series of studies from our laboratory 6, 20 have demonstrated that the upregulated AT 1 R expression and the enhanced AT 1 R-related intracellular signaling pathway in the RVLM play a critical role in the sympathoexcitation in the CHF condition, similar to that observed in hypertension. 7 Interestingly, in the current study, we found that although AT 1 R protein expression in the RVLM of CHF rats was upregulated, the AT 2 R was significantly downregulated and therefore greatly increased the ratio of AT 1 R to AT 2 R protein expression from 2.1Ϯ0.4 in sham to 13.8Ϯ0.7 in CHF (Figure 1) . Although the physiological roles of central AT 2 R in whole animals are unclear, the patch clamp data from the cultured individual neurons of the hypothalamus and brainstem clearly demonstrated an increase in the potassium current induced by this receptor, 11, 21 an effect contrary to that of the AT 1 R on neuronal channel function. 22 The functions and intracellular signaling pathways of the AT 2 R in most peripheral tissues and organs also are opposite to that of the AT 1 R. For example, stimulating AT 2 R induces vasodilation, stimulates nitric oxide production, and inhibits reactive oxygen species generation. 23 Taken together, these data led us to postulate that the balance between AT 1 R and AT 2 R in the RVLM may be critical to maintain sympathetic tone in normal conditions and that the downregulated AT 2 R combined with the upregulated AT 1 R in the RVLM may contribute to the sympathoexcitation in the CHF state. The mechanism for the ameliorating effects of AT 2 R stimulation on the responses to AT 1 R stimulation in the present experiments is not completely clear; however, a potential decrease in neuronal potassium current induced by the downregulation of AT 2 R expression (ie, dominance of AT 1 R expression) may imply facilitated neuronal excitability and exaggerated sympathetic outflow. Interestingly, microinjection of CGP42112, a specific AT 2 R agonist, into the RVLM evoked a significant hypotension, bradycardia, and decreased RSNA, a completely opposite effect to the well-known role induced by central AT 1 R stimulation. These data provide direct evidence showing physiological significance of brain AT 2 R in the regulation of autonomic function. Moreover, the effects of AT 2 R in the RVLM were completely blocked by pretreatment with the AT 2 R antagonist, PD123319, demonstrating the specificity of this effect. Support for our hypothesis comes from mice lacking AT 2 Rs. Siragy et al 24 reported that AT 2 R-null mice had slightly elevated systolic blood pressure compared with that of wild-type control mice. Infusion of a subpressor dose of Ang II failed to induce a change of blood pressure in wild-type mice but significantly increased blood pressure in AT 2 R knockout mice. Moreover, Li et al 25 found that injection of Ang II into the cerebral ventricle evoked a larger increase in blood pressure in AT 2 R knockout mice than that in wild-type mice. In wild-type mice, central injection of Ang II plus PD123319 initiated a greater pressor response than that induced by Ang II alone. The majority of neuronal AT 2 R intracellular signaling pathways are mediated by different mediators from that of AT 1 R.
It has been demonstrated in neurons cultured from neonatal rat hypothalamus and brainstem that inhibitory G proteins, phospholipase A2, and protein phosphatase 2A are involved in the AT 2 R-dependent increase in potassium current. 21, 26, 27 AT 2 R activation stimulates protein phosphatase 2A activity 28 and protein phosphatase 2A may directly participate in a dephosphorylation-mediated activation of the potassium channel. Zu et al 13 explored the involvement of a series of arachidonic acid metabolites in the AT 2 R-evoked increase in the potassium current in cultured neurons and demonstrated that the pathway of arachidonic acid metabolism is responsible for the modulation of potassium currents by AT 2 R. Indeed, in the current study, we found that pretreatment with 5,8,11,14-eicosatetraynoic acid, a general inhibitor of arachidonic acid metabolism, partially attenuated the activation of AT 2 R-induced suppression of sympathetic outflow ( Figure 5 ).
In the current study, we found that microinjection of Ang II into the RVLM evoked a significant pressor, tachycardia, and sympathoexcitation in both sham and CHF rats with a greater sympathetic response in CHF rats (Figure 3 ). This differential effect of Ang II in the RVLM between sham and CHF animals appears to be due to the increased AT 1 R and decreased AT 2 R expressions in the CHF state compared with sham. Indeed, when Ang II was microinjected into the RVLM after pretreatment with PD123319, we found enhanced sympathetic responses only in sham but not in CHF rats ( Figure  4 ). These data suggest that, in the normal condition, simultaneously activating AT 1 R and AT 2 R in the RVLM produced smaller responses than that induced by stimulating AT 1 R alone. This implies that the opposing effects of AT 2 R and AT 1 R in the RVLM play a role in the maintenance of sympathetic outflow. On the other hand, in the CHF state, loss of this opposing influence due to the downregulation of AT 2 R may contribute to the sympathoexcitation.
Stimulation of AT 2 R in the RVLM by CGP42112 induced inhibition of cardiovascular activity and sympathetic outflow exhibits regional specificity. In normal rats, microinjection of CGP42112 into the vicinity of RVLM, which had no response to L-glutamate, evoked no change in blood pressure, HR, and RSNA. Interestingly, microinjection of CGP42112 into the caudal ventrolateral medulla where L-glutamate often generates inhibition of sympathetic nerve activity evoked pressor and sympathoexcitatory effects (data not shown).
Perspectives
In a recently published paper, 29 we reported a decrease in nocturnal arterial pressure coincident with a decrease in urine concentration of noradrenaline and 24-hour noradrenaline excretion in normal, conscious rats after RVLM overexpression of AT 2 R by adenoviral transfection. In the current experiment, we documented the negative influence of stimulating endogenous AT 2 R in the RVLM on sympathetic outflow in normal rats and the weakened AT 2 R pathway in the RVLM of CHF rats, providing further insights into the physiological and pathological significance of AT 2 R in the neural control of autonomic and circulatory function. In future experiments, we will observe the potential beneficial effects of AT 2 R overexpression in the RVLM of CHF rats on heart failure state by AT 2 R-adenoviral transfection. Moreover, the first selective nonpeptide AT 2 R agonist, Compound 21, has been synthesized recently by Wan et al. 30 It is intriguing to speculate substances such as this may hold potential and promise for the treatment of such diseases characterized by sympathoexcitation such as CHF and hypertension.
